glutathione tumor suppressor Cysteine metabolic circuitries: druggable targets in cancer JCI - Suppression of the
JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma Human cancer associated fibroblasts enhance glutathione levels and antagonize drug induced prostate cancer cell death Cell Death & Disease Utilizing glutathione triggered nanoparticles to enhance chemotherapy of lung cancer by reprograming the tumor microenvironment ScienceDirect Frontiers SLC7A11: the Achilles heel of tumor? Glutathione mediated nanomedicines for cancer diagnosis and therapy ScienceDirect
Pay in 4 interest-free payments of $6.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




